0001209191-20-029924.txt : 20200518 0001209191-20-029924.hdr.sgml : 20200518 20200518082229 ACCESSION NUMBER: 0001209191-20-029924 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200515 FILED AS OF DATE: 20200518 DATE AS OF CHANGE: 20200518 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Butchko Julia G. CENTRAL INDEX KEY: 0001796290 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38906 FILM NUMBER: 20888108 MAIL ADDRESS: STREET 1: 320 W 37TH STREET, 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10016 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Immunovant, Inc. CENTRAL INDEX KEY: 0001764013 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 832771572 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 320 WEST 37TH STREET CITY: NEW YORK STATE: NY ZIP: 10018 BUSINESS PHONE: 917-580-3099 MAIL ADDRESS: STREET 1: 320 WEST 37TH STREET CITY: NEW YORK STATE: NY ZIP: 10018 FORMER COMPANY: FORMER CONFORMED NAME: Health Sciences Acquisitions Corp DATE OF NAME CHANGE: 20190108 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-05-15 0 0001764013 Immunovant, Inc. IMVT 0001796290 Butchko Julia G. 320 W 37TH STREET, 3RD FLOOR NEW YORK NY 10018 0 1 0 0 Chief Dev. & Tech. Officer Stock Option (right to buy) 19.01 2020-05-15 4 A 0 319700 0.00 A 2030-05-14 Common Stock 319700 319700 D 25% of the shares underlying the option vests on the first anniversary of the grant date, and the remainder vests in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date. /s/ W. Bradford Middlekauff, attorney-in-fact for Julia G. Butchko 2020-05-18